ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,604.37
(
0.41%
)
US Tech 100
15,700.80
(
0.54%
)
Dow Jones
36,247.87
(
0.36%
)
Brent Oil
75.965
(
0.0%
)
Bitcoin
43,950.01
(
-0.52%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Agenus Inc (AGEN)

  7. Agenus Inc (AGEN) News

AGEN Agenus Inc

0.7499
-0.0606 (-7.48%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Agenus Inc AGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.0606 -7.48% 0.7499 19:59:02
Open Price Low Price High Price Close Price Prev Close
0.8034 0.7422 0.8102 0.7465 0.8105
more quote information »

Recent News

Date Time Source Heading
12/08/202316:15EDGAR2Form 8-K - Current report
11/17/202316:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202306:30EDGAR2Form 8-K - Current report
11/07/202306:30BWAgenus Reports Third Quarter 2023 Results
10/26/202309:05BWAgenus to Provide Third Quarter 2023 Financial Report and..
10/22/202312:00BWAgenus Unveils New and Updated Botensilimab Data in..
10/21/202304:15BWESMO 2023: Agenus’ Botensilimab/Balstilimab Combination..
10/16/202317:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202307:30BWAgenus Completes Enrollment in Randomized Phase 2 Clinical..
10/06/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202307:30BWAgenus To Host BOT/BAL Program Update at ESMO 2023
10/04/202317:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/01/202316:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
8/31/202317:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/28/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/28/202307:30BWAgenus to Participate in September Investor Conferences
8/23/202308:00EDGAR2Form 8-K - Current report
8/23/202308:00BWAgenus Prioritizes Resources to Accelerate Registration and..
8/09/202308:30BWSaponiQx Announces Breakthrough in Scaling Up of STIMULON™..
8/08/202316:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202307:30EDGAR2Form 8-K - Current report
8/08/202307:30BWAgenus Reports Second Quarter 2023 Results
7/28/202307:30BWAgenus Botensilimab/Balstilimab Data Update in Sarcomas..
7/26/202307:30BWAgenus to Provide Second Quarter 2023 Financial Report and..
7/20/202307:30BWAgenus Expands Executive Leadership Team
7/06/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/06/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/06/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/30/202311:15BWESMO GI Data: Agenus' Botensilimab/Balstilimab Combination..
6/05/202309:49BWAgenus Presents Positive Efficacy and Safety Outcomes for..
6/05/202307:30BWAgenus Announces Virtual Annual Shareholders Meeting
5/25/202307:30BWAgenus to Participate in Jefferies Healthcare Conference
5/09/202308:00BWAgenus Provides Corporate Update and First Quarter 2023..
5/03/202309:08BWAgenus Selected for Late-Breaking Oral Presentation at..
4/26/202310:35BWAgenus to Present at the American Society of Clinical..
4/25/202307:30BWAgenus to Provide Corporate Update and First Quarter 2023..
4/24/202307:30BWAgenus to Participate in May Investor Conferences
4/17/202307:30BWAgenus Receives Fast Track Designation for Botensilimab and..
4/12/202316:30GLOBEGain Therapeutics Appoints C. Evan Ballantyne as Chief..
3/30/202308:41BWAgenus Announces Dividend of 5 Million Shares of MiNK..
3/27/202309:45BWAgenus’ Botensilimab in Combination with Balstilimab Shows..
3/14/202307:30GLOBEAgenus Reports Fourth Quarter and Full Year 2022 Financial..
3/12/202320:29GLOBEAgenus Cancels Conference Call to Discuss the Company’s..
3/11/202311:24GLOBEAgenus Schedules Conference Call to Discuss the Company’s..
2/28/202307:30GLOBEAgenus to Provide Corporate Update and Fourth Quarter & Full..
1/26/202307:30GLOBEAgenus to Participate in February Investor Conferences
1/23/202307:30GLOBEAgenus Presents Clinical Data Demonstrating Durable..

Your Recent History

NASDAQ
AGEN
Agenus
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com